Research Article

Genetic alterations and pathways in patients with Hereditary Angioedema of Unknown Cause (U-HAE)

Volume: 34 Number: 3 October 27, 2021
  • Hande Kaymakcalan *
  • Hande Alp
  • Ahmet Okay Caglayan
  • Okan Gulbahar
  • Emine Nihal Gokmen
  • Emrah Nıkerel
EN

Genetic alterations and pathways in patients with Hereditary Angioedema of Unknown Cause (U-HAE)

Abstract

Objective: Hereditary angioedema ( HAE) with normal C1 inhibitor (HAE-nC1-INH), is a genetically complex, rare disease and
mutations in F12, ANGPT1, PLG, MYOF genes are found in some families with HAE-nC1-INH. However, often a specific mutation
cannot be identified and this type is called as hereditary angioedema of unknown cause (U-HAE). Our aim was to identify putative
causative genetic alterations and/or pathways by whole exome sequencing in patients with U-HAE.
Patients and Methods: Nine patients from 8 families between the ages of 3 to 63 years with U-HAE and 6 controls were enrolled for
the study and whole exome sequencing were performed.
Results: No significant difference was found between the case and control group for the a priori suspected set of genes. Variants in the
genes; RAMP2, IL6, GP1BA, C1QBP were significantly different between U-HAE and control group. Downstream functional analysis
found that blood coagulation pathways were enriched in these genes.
Conclusion: Proteins that are not involved in contact pathways may also play a role in U-HAE. These variants need to be replicated in
larger cohorts and studied at the functional level to verify our findings.

Keywords

References

  1. [1] Cicardi M, Aberer W, Banerji A et al. HAWK under the patronage of EAACI (European Academy of Allergy and Clinical Immunology). Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group. Allergy 2014;69:602-16. doi: 10.1111/all.12380.
  2. [2] Bork K, Barnstedt SE, Koch P, Traupe H. Hereditary angioedema with normal C1-inhibitor activity in women. Lancet 2000;356(9225):213-7. doi: 10.1016/S0140- 6736(00)02483-1.
  3. [3] Dewald G, Bork K. Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor. Biochem Biophys Res Commun 2006 May 19;343(4):1286-9. doi: 10.1016/j.bbrc.2006.03.092.
  4. [4] Cichon S, Martin L, Hennies HC et al. Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III. Am J Hum Genet 2006 Dec;79(6):1098- 104. doi: 10.1086/509899.
  5. [5] Bodian DL, Vilboux T, Hauser NS. Genotype-first analysis of a generally healthy population cohort supports genetic testing for diagnosis of hereditary angioedema of unknown cause. Allergy Asthma Clin Immunol 2019; 16:15:32. doi: 10.1186/ s13223.019.0346-1.
  6. [6] Hieter P, Boguski M. Functional genomics: it’s all how you read it. Science 1997; 24:278(5338):601-2. doi: 10.1126/ science.278.5338.601.
  7. [7] Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods 2012;9:357-9.
  8. [8] Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009; 25:1754- 60. doi: 10.1093/bioinformatics/btp324

Details

Primary Language

English

Subjects

Clinical Sciences

Journal Section

Research Article

Authors

Hande Kaymakcalan * This is me
Türkiye

Hande Alp This is me
Türkiye

Ahmet Okay Caglayan This is me
Türkiye

Okan Gulbahar This is me
Türkiye

Emine Nihal Gokmen This is me
Türkiye

Emrah Nıkerel This is me
Türkiye

Publication Date

October 27, 2021

Submission Date

March 12, 2021

Acceptance Date

June 7, 2021

Published in Issue

Year 2021 Volume: 34 Number: 3

APA
Kaymakcalan, H., Alp, H., Caglayan, A. O., Gulbahar, O., Gokmen, E. N., & Nıkerel, E. (2021). Genetic alterations and pathways in patients with Hereditary Angioedema of Unknown Cause (U-HAE). Marmara Medical Journal, 34(3), 274-278. https://doi.org/10.5472/marumj.1009115
AMA
1.Kaymakcalan H, Alp H, Caglayan AO, Gulbahar O, Gokmen EN, Nıkerel E. Genetic alterations and pathways in patients with Hereditary Angioedema of Unknown Cause (U-HAE). Marmara Med J. 2021;34(3):274-278. doi:10.5472/marumj.1009115
Chicago
Kaymakcalan, Hande, Hande Alp, Ahmet Okay Caglayan, Okan Gulbahar, Emine Nihal Gokmen, and Emrah Nıkerel. 2021. “Genetic Alterations and Pathways in Patients With Hereditary Angioedema of Unknown Cause (U-HAE)”. Marmara Medical Journal 34 (3): 274-78. https://doi.org/10.5472/marumj.1009115.
EndNote
Kaymakcalan H, Alp H, Caglayan AO, Gulbahar O, Gokmen EN, Nıkerel E (October 1, 2021) Genetic alterations and pathways in patients with Hereditary Angioedema of Unknown Cause (U-HAE). Marmara Medical Journal 34 3 274–278.
IEEE
[1]H. Kaymakcalan, H. Alp, A. O. Caglayan, O. Gulbahar, E. N. Gokmen, and E. Nıkerel, “Genetic alterations and pathways in patients with Hereditary Angioedema of Unknown Cause (U-HAE)”, Marmara Med J, vol. 34, no. 3, pp. 274–278, Oct. 2021, doi: 10.5472/marumj.1009115.
ISNAD
Kaymakcalan, Hande - Alp, Hande - Caglayan, Ahmet Okay - Gulbahar, Okan - Gokmen, Emine Nihal - Nıkerel, Emrah. “Genetic Alterations and Pathways in Patients With Hereditary Angioedema of Unknown Cause (U-HAE)”. Marmara Medical Journal 34/3 (October 1, 2021): 274-278. https://doi.org/10.5472/marumj.1009115.
JAMA
1.Kaymakcalan H, Alp H, Caglayan AO, Gulbahar O, Gokmen EN, Nıkerel E. Genetic alterations and pathways in patients with Hereditary Angioedema of Unknown Cause (U-HAE). Marmara Med J. 2021;34:274–278.
MLA
Kaymakcalan, Hande, et al. “Genetic Alterations and Pathways in Patients With Hereditary Angioedema of Unknown Cause (U-HAE)”. Marmara Medical Journal, vol. 34, no. 3, Oct. 2021, pp. 274-8, doi:10.5472/marumj.1009115.
Vancouver
1.Hande Kaymakcalan, Hande Alp, Ahmet Okay Caglayan, Okan Gulbahar, Emine Nihal Gokmen, Emrah Nıkerel. Genetic alterations and pathways in patients with Hereditary Angioedema of Unknown Cause (U-HAE). Marmara Med J. 2021 Oct. 1;34(3):274-8. doi:10.5472/marumj.1009115